These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
290 related articles for article (PubMed ID: 34866323)
1. Factors associated with lymph node metastasis upstage after resection for patients with micropapillary lung adenocarcinoma. Matsushima K; Sonoda D; Mitsui A; Tamagawa S; Hayashi S; Naito M; Matsui Y; Shiomi K; Satoh Y Thorac Cancer; 2022 Jan; 13(1):48-53. PubMed ID: 34866323 [TBL] [Abstract][Full Text] [Related]
2. Minor components of micropapillary and solid subtypes in lung invasive adenocarcinoma (≤ 3 cm): PET/CT findings and correlations with lymph node metastasis. Chang C; Sun X; Zhao W; Wang R; Qian X; Lei B; Wang L; Liu L; Ruan M; Xie W; Shen J Radiol Med; 2020 Mar; 125(3):257-264. PubMed ID: 31823295 [TBL] [Abstract][Full Text] [Related]
4. [Potential value of FDG PET-CT in predicting occult lymph node metastasis in clinical stage ⅠA lung adenocarcinoma]. Lyu L; Liu Y; Wang XY; Zhang ZK; Tao XL; Yang L; Wu N Zhonghua Zhong Liu Za Zhi; 2019 Jun; 41(6):441-447. PubMed ID: 31216830 [No Abstract] [Full Text] [Related]
5. Standardized Uptake Values in the Primary Lesions of Non-Small-Cell Lung Cancer in FDG-PET/CT Can Predict Regional Lymph Node Metastases. Nakamura H; Saji H; Marushima H; Kimura H; Tagaya R; Kurimoto N; Hoshikawa M; Takagi M Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1388-93. PubMed ID: 25900205 [TBL] [Abstract][Full Text] [Related]
6. Risk Factors for Predicting Occult Lymph Node Metastasis in Patients with Clinical Stage I Non-small Cell Lung Cancer Staged by Integrated Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography. Kaseda K; Asakura K; Kazama A; Ozawa Y World J Surg; 2016 Dec; 40(12):2976-2983. PubMed ID: 27456499 [TBL] [Abstract][Full Text] [Related]
7. A standardized technique of systematic mediastinal lymph node dissection by video-assisted thoracoscopic surgery (VATS) leads to a high rate of nodal upstaging in early-stage non-small cell lung cancer. Reichert M; Steiner D; Kerber S; Bender J; Pösentrup B; Hecker A; Bodner J Surg Endosc; 2016 Mar; 30(3):1119-25. PubMed ID: 26169635 [TBL] [Abstract][Full Text] [Related]
8. The maximum standardized uptake value of fluorodeoxyglucose positron emission tomography of the primary tumour is a good predictor of pathological nodal involvement in clinical N0 non-small-cell lung cancer. Miyasaka Y; Suzuki K; Takamochi K; Matsunaga T; Oh S Eur J Cardiothorac Surg; 2013 Jul; 44(1):83-7. PubMed ID: 23233074 [TBL] [Abstract][Full Text] [Related]
9. Outcomes and predictive factors for pathological node-positive in radiographically pure-solid, small-sized lung adenocarcinoma. Kayata H; Isaka M; Terada Y; Mizuno K; Yasuura Y; Kojima H; Ohde Y Gen Thorac Cardiovasc Surg; 2019 Jun; 67(6):544-550. PubMed ID: 30627979 [TBL] [Abstract][Full Text] [Related]
10. Predictive value of metabolism and its heterogeneity parameters measured by preoperative Yang Z; Liu Z; Zhang S; Qiu B; Chai H; Wei L; Li N; He Z; Luo Y; Wei H; Gan M; Xiao G Hell J Nucl Med; 2024; 27(2):78-84. PubMed ID: 39097804 [TBL] [Abstract][Full Text] [Related]
11. Clinicopathological Characteristics of Lung Adenocarcinoma with Unexpected Lymph Node Metastasis. Haruki T; Wakahara M; Matsuoka Y; Miwa K; Araki K; Taniguchi Y; Nakamura H Ann Thorac Cardiovasc Surg; 2017 Aug; 23(4):181-187. PubMed ID: 28539542 [TBL] [Abstract][Full Text] [Related]
12. Video-assisted thoracic surgery systematic mediastinal nodal dissection and stage migration: impact on clinical pathway. Amer K; Khan AZ; Singh N; Addis B; Jogai S; Harden S; Peebles C; Brown I Eur J Cardiothorac Surg; 2011 Dec; 40(6):1474-81. PubMed ID: 21497109 [TBL] [Abstract][Full Text] [Related]
14. Analysis of Segmental Lymph Node Metastasis and Clinical Features in cT1N0M0 Lung Adenocarcinoma. Sun G; Sun Y; Zou Z; Xu S Biomed Res Int; 2020; 2020():2842604. PubMed ID: 32149096 [TBL] [Abstract][Full Text] [Related]
15. Prediction of pathologic node-negative clinical stage IA lung adenocarcinoma for optimal candidates undergoing sublobar resection. Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1365-71. PubMed ID: 22883546 [TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic Factors Associated With Occult Lymph Node Metastasis in Patients With Clinically Diagnosed N0 Lung Adenocarcinoma. Moon Y; Kim KS; Lee KY; Sung SW; Kim YK; Park JK Ann Thorac Surg; 2016 May; 101(5):1928-35. PubMed ID: 26952299 [TBL] [Abstract][Full Text] [Related]
17. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification predicts occult lymph node metastasis in clinically mediastinal node-negative lung adenocarcinoma. Yeh YC; Kadota K; Nitadori J; Sima CS; Rizk NP; Jones DR; Travis WD; Adusumilli PS Eur J Cardiothorac Surg; 2016 Jan; 49(1):e9-e15. PubMed ID: 26377636 [TBL] [Abstract][Full Text] [Related]
18. Predictive accuracy of lepidic growth subtypes in early-stage adenocarcinoma of the lung by quantitative CT histogram and FDG-PET. Eriguchi D; Shimada Y; Imai K; Furumoto H; Okano T; Masuno R; Matsubayashi J; Kajiwara N; Ohira T; Ikeda N Lung Cancer; 2018 Nov; 125():14-21. PubMed ID: 30429012 [TBL] [Abstract][Full Text] [Related]
19. Predictive factors for lymph node metastasis in clinical stage IA lung adenocarcinoma. Ye B; Cheng M; Li W; Ge XX; Geng JF; Feng J; Yang Y; Hu DZ Ann Thorac Surg; 2014 Jul; 98(1):217-23. PubMed ID: 24841547 [TBL] [Abstract][Full Text] [Related]
20. Long-Term Outcomes After Sublobar Resection Versus Lobectomy in Patients With Clinical Stage IA Lung Adenocarcinoma Meeting the Node-Negative Criteria Defined by High-Resolution Computed Tomography and [ Tsutani Y; Nakayama H; Ito H; Handa Y; Mimae T; Miyata Y; Okada M Clin Lung Cancer; 2021 May; 22(3):e431-e437. PubMed ID: 32665166 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]